Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07612813 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Eligibility criteria expanded, about 22 words · Site details revised · Study description expanded, about 3 words Show 3 more changesShow less
    • Eligibility criteria expanded, about 22 words
    • Site details revised
    • Study description expanded, about 3 words
  2. Re-verified, no change to tracked fieldsv3
  3. Recruitment opened Primary and study completion dates: Sep 24, 2027 to Sep 13, 2027 · Start date changed from estimate of Jun 24, 2026 to Jun 29, 2026 · Site details revisedv2 Show 3 more changesShow less
    • Primary and study completion dates: Sep 24, 2027 to Sep 13, 2027
    • Start date changed from estimate of Jun 24, 2026 to Jun 29, 2026
    • Site details revised
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AstraZeneca
727 trials monitored
See 61 trials at risk
The purpose of this study is to evaluate the safety and PK of AZD7760 when given as an intravenous (IV) infusion to healthy Japanese adult participants.
Trial Details
NCT Number NCT07612813
Lead Sponsor AstraZeneca
Collaborators: Parexel
Conditions Staphylococcus Aureus Bloodstream Infection
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov